Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

ABSTRACT: Whole exome sequencing for multiple myeloma.

PROVIDER: PRJNA578181 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR10305000_1.fastq.gz	Fastqsanger.gz
	SRR10305000_2.fastq.gz	Fastqsanger.gz
	SRR10305001_1.fastq.gz	Fastqsanger.gz
	SRR10305001_2.fastq.gz	Fastqsanger.gz
	SRR10305002_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 72

Similar Datasets

MM in murine models: WES

Project description:Characterization of the mutational landscape of the 5T murine models for multiple myeloma, by whole-exome sequencing.

2018-10-09 | E-MTAB-5282 | biostudies-arrayexpress

CIDR: Whole Exome Sequencing of Multiple Myeloma

Project description:CIDR: Whole Exome Sequencing of Multiple Myeloma

| PRJNA746363 | ENA

CIDR: Whole Exome Sequencing of Multiple Myeloma

Project description:CIDR: Whole Exome Sequencing of Multiple Myeloma

| PRJNA746364 | ENA

Project description:Whole exome sequencing on patients with extramedullary multiple myeloma

| PRJNA1114305 | ENA

Project description:Human Multiple Myeloma CD138 Cell Population Whole Exome Sequencing

| PRJNA482153 | ENA

Proteasome inhibitor-induced modulation reveals the spliceosome as a specific therapeutic vulnerability in multiple myeloma

Project description:Resistance to proteasome inhibitors (PIs) is a ubiquitous clinical concern in multiple myeloma. We proposed that signaling-level responses after PI would reveal new means to enhance efficacy. Unbiased phosphoproteomics after the PI carfilzomib surprisingly demonstrated the most prominent phosphorylation changes on spliceosome components. Spliceosome modulation was invisible to RNA or protein abundance alone. Transcriptome analysis demonstrated broad-scale intron retention suggestive of PI-specific splicing interference. Direct spliceosome inhibition synergized with carfilzomib and showed potent anti-myeloma activity. Functional genomics and exome sequencing further supported the spliceosome as a specific vulnerability in myeloma. Our results propose splicing interference as an unrecognized modality of PI mechanism, reveal additional modes of spliceosome modulation, and suggest spliceosome targeting as a promising therapeutic strategy in myeloma.

2020-02-21 | PXD012172 | Pride

Murine models of multiple myeloma: WGS

Project description:Characterization of genomic landscape of the 5T murine models for multiple myeloma, by whole-genome sequencing

2018-10-09 | E-MTAB-5302 | biostudies-arrayexpress

Proteogenomic profiling of urine extracellular vesicles

Project description:Whole exome sequencing of cancer tissues and proteomic data of cancer, CTD-EV, urine EV

2026-03-10 | PXD061615 | JPOST Repository